CompletedNot Applicable

Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

Egypt200 participantsStarted 2017-01-01

Plain-language summary

The purpose of this study is to determine the prevalence of positive antiphospholipid antibodies among women with preeclampsia and to determine the effect of antiphospholipid antibodies on the severity of preeclampsia and the obstetric outcomes

Who can participate

Age range20 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women with preeclampsia. Exclusion Criteria: * Women with systemic autoimmune disease. * Women with active thromboembolic disorders. * Women with history of previous thromboembolic disorders.

What they're measuring

Rate of positive antiphospholipid antibodies

Timeframe: 20 weeks to 42 weeks gestational age

Trial details

NCT IDNCT02699437

SponsorMohamed Sayed Abdelhafez

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Preeclampsia trials